A smaller body burns less energy at rest, during activity, and even during digestion
The mean follow-up on-treatment was 181 days (median 155 days, IQR 71 to 290 days) for tirzepatide initiators and 174 days (median 148 days, IQR 82 to 254 days) for semaglutide initiators
Most researchers who reach this dose are well past the initial side effect period and have adapted to the GLP-1 mechanism
Alternatively, they may suggest switching to a non-oral form, such as a Mirena coil, which provides reliable, consistent local progesterone release directly where its needed
C., & Saadoun, S
Chem Eng J 390:124621 Wang B, Zeng Y, Liu S, Zhou M, Fang H, Wang Z et al (2023) ZIF-8 induced hydroxyapatite-like crystals enabled superior osteogenic ability of MEW printing PCL scaffolds